Anticorps Monoclonal anti-NeutraControl IL-23 p19

NeutraControl IL-23 p19 Monoclonal Antibody for Non-Neutralization, ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, souris

Applications

Non-Neutralization, ELISA

Conjugaison

Non conjugué

CloneNo.

1A9B9

N° de cat : 69506-1-Ig

Synonymes

IL 23, IL 23 A, IL 23 subunit alpha, IL 23A, IL 23p19, IL-23 p19, IL23A, IL23P19, Interleukin 23 subunit alpha, Interleukin 23 subunit p19, P19, SGRF



Informations sur le produit

69506-1-Ig cible IL-23 p19 dans les applications de Non-Neutralization, ELISA et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène human Humankine IL-23 p19 protein HZ-1254
Nom complet interleukin 23, alpha subunit p19
Symbole du gène IL23A
Identification du gène (NCBI) 51561
Conjugaison Non conjugué
Forme Lyophilized Powder
Méthode de purification Purification par protéine A
Tampon de stockage PBS stérile.
Endotoxin<0.1 EU/μg
ReconstitutionThis product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.
Stability and StorageLyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.

Informations générales

Interleukin 23 (IL-23) is a member of the IL12 cytokine family and composed of two subunits, IL12p40 and IL23p19. It is produced by antigen presenting cells and has been shown to promote the production and survival of a distinct lineage of T-cells called TH17 cells. A functional receptor for IL-23 (the IL-23 receptor) has been identified and is composed of IL-12Rβ1 and IL-23R. IL-23 is expressed chiefly by the macrophages and DCs. The IL-23R is found on memory T cells, NKT cells, macrophages, DCs, and naive T cells upon activation by TGF-βand IL-6. The main biological effects of IL-23 identified initially are stimulation of antigen presentation by DCs, T cell differentiation to Th17 cells, and production of interferon-γ (IFN-γ). IL-23 acts also as an end-stage effector cytokine through direct action on macrophages (PMID: 16393998;15657292;12023369;12610626).

This antibody is a neutralizing control antibody for IL-23, the immunogen is the same as Neutrakine 69006-1-Ig but could not neutralize human IL-23.